: Trading at approximately $6.55, it is noted for its attractive valuation (9.3x forward P/E) and soaring earnings per share.

: Priced around $4.09, this biotech firm has a projected EPS growth of over 150% for the next year.

: Priced near $6.07, analysts suggest it could beat the market in 2026 due to strong engagement with younger demographics and expanding free cash flow. Penny Stocks with High Return Potential

Penny stocks (typically under $5) carry higher risk but offer significant upside potential:

: A REIT priced at roughly $8.60 with a forward P/E ratio of 7.20 and double-digit projected EPS growth.

: Trading near $2.96, it shows strong projected EPS growth of approximately 58%.

These stocks are often targeted for their high growth potential relative to their low entry price: